Related Experiment Video
Updated: May 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis
Leah A Marquez-Curtis1, Neeta Shirvaikar, A Robert Turner
1Canadian Blood Services R&D, Edmonton, Alberta T6G 2R8, Canada. anna.janowska@blood.ca.
Abstract:
Membrane type-1 matrix metalloproteinase (MT1-MMP) has been implicated in tumor invasion, as well as trafficking of normal hematopoietic cells, and acts as a physiologic activator of proMMP-2. In this study we examined MT1-MMP expression in primary acute myeloid leukemia (AML) cells. Because tumor necrosis factor (TNF)-α is known to be elevated in AML, we also investigated the effect of TNF-α on MT1-MMP expression. We found (i) MT1-MMP mRNA expression in 41 out of 43 primary AML samples tested; (ii) activation of proMMP-2 in co-cultures of AML cells with normal bone marrow stromal cells; and (iii) inhibition of proMMP-2 activation and trans-Matrigel migration of AML cells by gene silencing using MT1-MMP siRNA. Moreover, recombinant human TNF-α upregulated MT1-MMP expression in AML cells resulting in enhanced proMMP-2 activation and trans-Matrigel migration. Thus, AML cells express MT1-MMP and TNF-α enhances it leading to increased MMP-2 activation and most likely contributing to the invasive phenotype. We suggest that MT1-MMP, together with TNF-α, should be investigated as potential therapeutic targets in AML.
Insights
Acute myeloid leukemia (AML) cells express membrane type-1 matrix metalloproteinase (MT1-MMP), which enhances tumor invasion. Tumor necrosis factor-alpha (TNF-α) upregulates MT1-MMP, increasing proMMP-2 activation and AML cell migration.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Membrane type-1 matrix metalloproteinase (MT1-MMP) is involved in tumor invasion and hematopoietic cell trafficking.
- MT1-MMP physiologically activates proMMP-2.
- Tumor necrosis factor-alpha (TNF-α) is elevated in acute myeloid leukemia (AML).
Purpose of the Study:
- To investigate MT1-MMP expression in primary AML cells.
- To determine the effect of TNF-α on MT1-MMP expression in AML.
- To assess the role of MT1-MMP in AML cell invasion and proMMP-2 activation.
Main Methods:
- Analysis of MT1-MMP mRNA expression in primary AML samples.
- Co-culture experiments with AML cells and bone marrow stromal cells.
- Gene silencing of MT1-MMP using siRNA.
- Treatment with recombinant human TNF-α.
- Assay of proMMP-2 activation and trans-Matrigel migration.
Main Results:
- MT1-MMP mRNA was detected in 41 out of 43 primary AML samples.
- AML cells activated proMMP-2 when co-cultured with stromal cells.
- MT1-MMP gene silencing inhibited proMMP-2 activation and AML cell migration.
- Recombinant TNF-α upregulated MT1-MMP expression, enhancing proMMP-2 activation and migration.
Conclusions:
- AML cells express MT1-MMP, contributing to their invasive potential.
- TNF-α enhances MT1-MMP expression in AML, leading to increased MMP-2 activation.
- MT1-MMP and TNF-α are potential therapeutic targets for AML.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Role of Matrix Metalloproteases in Degradation of ECM
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...

